Michael Ehlers
Neuroscience Chief Scientific Officer
Pfizer
From this contributor
A cautionary tale for autism drug development
Poorly designed animal drug studies for motor disorders have led to spurious conclusions for the clinical trials that follow. This may be even more true for autism research, says Michael Ehlers.
SHANK mutations converge at neuronal junctions in autism
SHANK3, one of the strongest candidate genes for autism, has the potential to be a molecular entry point into understanding the synaptic, developmental and circuit origins of the disorder.
SHANK mutations converge at neuronal junctions in autism
Drug zone
Rodent and stem cell models remain challenging for developing psychiatric drugs, says Michael Ehlers, chief scientific officer of neuroscience at Pfizer.
Explore more from The Transmitter
‘Shock and pain’ after ICE detains Princeton neuroscientist
Eva Yi Xie, a third-year graduate student in Carlos Brody’s lab at Princeton University, was detained yesterday at an airport in Washington, D.C., while traveling from the Society for Neuroscience meeting.
‘Shock and pain’ after ICE detains Princeton neuroscientist
Eva Yi Xie, a third-year graduate student in Carlos Brody’s lab at Princeton University, was detained yesterday at an airport in Washington, D.C., while traveling from the Society for Neuroscience meeting.
Training graduate students as a teaching professor
Mayank Chugh instructs graduate students in a range of molecular biology techniques at the University of Maryland and carves out time to do metascience research as well.
Training graduate students as a teaching professor
Mayank Chugh instructs graduate students in a range of molecular biology techniques at the University of Maryland and carves out time to do metascience research as well.
Loss of Angelman-linked UBE3A gene triggers stress response in neurons
A failure to break down asparagine synthetase ultimately leads to stunted neuronal development.
Loss of Angelman-linked UBE3A gene triggers stress response in neurons
A failure to break down asparagine synthetase ultimately leads to stunted neuronal development.